Sherwin-Williams Analysts Slash Their Forecasts After Downbeat Q2 Earnings

Sherwin-Williams (SHW) reported worse-than-expected Q2 adjusted EPS of $3.38 against a $3.81 estimate, despite a marginal revenue beat at $6.31 billion. Crucially, the company significantly lowered its FY25 adjusted EPS guidance to $11.20-$11.50, falling well below the $11.88 consensus, and also reduced GAAP EPS projections. Despite these downward revisions, SHW shares saw a 1% gain, while analysts from Wells Fargo, JP Morgan, and Citigroup maintained their ratings but reduced price targets, signaling cautious sentiment despite the stock's immediate reaction.

Analysis

The Sherwin-Williams Company (SHW) reported a challenging second quarter, characterized by a significant earnings miss and a downward revision of its future guidance. The company's adjusted EPS of $3.38 fell materially short of the $3.81 Wall Street consensus, overshadowing a marginal revenue beat of $6.31 billion against a $6.30 billion estimate. The primary concern for investors is the lowered full-year 2025 outlook; adjusted EPS guidance was cut to $11.20-$11.50, a range now entirely below the $11.88 analyst consensus, signaling deteriorating profitability expectations. Similarly, GAAP EPS guidance was reduced to $10.11-$10.41, also below the $11.09 consensus. In response, analysts at firms including Wells Fargo, JP Morgan, and Citigroup uniformly lowered their price targets, reflecting a recalibration of valuation, although they maintained their existing Overweight or Neutral ratings. Paradoxically, SHW shares gained 1% following the announcement, a divergence that suggests the market may have priced in the weakness or is focusing on the stable, albeit vague, sales outlook which is projected to be up or down a low-single-digit percentage.

Key Decisions for Investors

• Investors should re-evaluate valuation models to reflect the new, lower FY25 adjusted EPS guidance of $11.20-$11.50, which indicates a weaker earnings trajectory than previously forecast.
• The 1% share price increase despite the earnings miss and guidance cut warrants caution; investors should monitor whether this price resilience is sustainable or if the market will later react to the weaker fundamentals.
• Note that while analysts maintained ratings like 'Overweight', the across-the-board price target reductions, such as JP Morgan's cut to $378 from $390, signal a more tempered view on the stock's near-term upside.
• Given the uncertain sales guidance of 'up or down a low-single-digit percentage', it is prudent to watch for leading indicators in the housing and construction markets that could sway revenues toward either end of that range.